Basic Information
Basic information for LINC00343-323-28aa
Peptide Name LINC00343-323-28aa
Genome Position chr13:105763743-105763826[+]
Species Human
Peptide Sequence MGGHLRRQARSHSVGETSVRSNNVGLLK
Peptide Length 28
Unique No (LINC00343-202-28aa,LINC00343-205-28aa,LINC00343-225-28aa,LINC00343-232-28aa,LINC00343-243-28aa,LINC00343-250-28aa,LINC00343-252-28aa,LINC00343-253-28aa,LINC00343-255-28aa,LINC00343-257-28aa,LINC00343-258-28aa,LINC00343-262-28aa,LINC00343-264-28aa,LINC00343-265-28aa,LINC00343-270-28aa,LINC00343-291-28aa,LINC00343-293-28aa,LINC00343-294-28aa,LINC00343-299-28aa,LINC00343-303-28aa,LINC00343-306-28aa,LINC00343-315-28aa,LINC00343-321-28aa,LINC00343-324-28aa,LINC00343-326-28aa,LINC00343-328-28aa)
Grand Average of Hydropathicity -0.7179
Relative Molecular Mass 3533.89
Experimental Evidences no
lncRNA ID/Name ENSG00000226620;LINC00343
Transcript ID/Name ENST00000670771;LINC00343-323
Transcript Length 1983
Coding Ability 0.4937
DNA Sequence Corresponding to Peptide ATGGGAGGACACCTGAGACGGCAGGCCAGAAGTCACTCAGTAGGAGAAACATCCGTTAGAAGTAATAATGTGGGATTGCTGAAG
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :